Literature DB >> 15777230

Treatment of hypertensive complications in pregnancy.

K H Coppage1, B M Sibai.   

Abstract

Hypertension is the most common medical disorder during pregnancy. Approximately 70 percent of women diagnosed with hypertension during pregnancy will have gestational hypertension-preeclampsia. The term gestational hypertension-preeclampsia is used to describe a wide spectrum of patients who may have only mild elevation in blood pressure to those with severe hypertension with various organ dysfunctions (acute gestational hypertension, preeclampsia, eclampsia, and the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). The exact incidence of gestational hypertension-preeclampsia in the United States is unknown. Estimates range from 6% to 8% of all pregnancies. The treatment of hypertensive disorders in pregnancy requires careful assessment of the maternal and fetal conditions. Therapeutic decisions must take into account fetal age, maternal symptoms, tests of fetal well-being, as well as maternal status, in order to ensure the best overall outcome. Treatment of mild gestational hypertension with antihypertensive medications has not been shown to improve outcome, however, in cases of severe disease treatment has been shown to be beneficial. The purpose of this review is to discuss the different treatment modalities used in the hypertensive disorders of pregnancy. Management strategies will not be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777230     DOI: 10.2174/1381612053381864

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  [Posterior reversible encephalopathy syndrome].

Authors:  D Staykov; S Schwab
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

2.  Atypical Eclampsia in a Pregnant Woman Infected by COVID-19.

Authors:  Maha Ahmad Odeh; Yousef S Abuzneid; Omar Badareen; Khaled Masarweh
Journal:  Case Rep Obstet Gynecol       Date:  2022-04-27

Review 3.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Women's preconceptional health and use of health services: implications for preconception care.

Authors:  Marianne M Hillemeier; Carol S Weisman; Gary A Chase; Anne-Marie Dyer; Michele L Shaffer
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

5.  Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.

Authors:  Josje Langenveld; Kim Broekhuijsen; Gert-Jan van Baaren; Maria G van Pampus; Anton H van Kaam; Henk Groen; Martina Porath; Martijn A Oudijk; Kitty W Bloemenkamp; Christianne J de Groot; Erik van Beek; Marloes E van Huizen; Herman P Oosterbaan; Christine Willekes; Ella J Wijnen-Duvekot; Maureen T M Franssen; Denise A M Perquin; Jan M J Sporken; Mallory D Woiski; Henk A Bremer; Dimitri N M Papatsonis; Jozien T J Brons; Mesruwe Kaplan; Bas W A Nij Bijvanck; Ben-Willen J Mol
Journal:  BMC Pregnancy Childbirth       Date:  2011-07-07       Impact factor: 3.007

6.  Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.

Authors:  Corine M Koopmans; Denise Bijlenga; Jan G Aarnoudse; Erik van Beek; Dick J Bekedam; Paul P van den Berg; Jan M Burggraaff; Erwin Birnie; Kitty W M Bloemenkamp; Addi P Drogtrop; Arie Franx; Christianne J M de Groot; Anjoke J M Huisjes; Anneke Kwee; Saskia le Cessie; Aren J van Loon; Ben W J Mol; Joris A M van der Post; Frans J M E Roumen; Hubertina C J Scheepers; Marc E A Spaanderman; Rob H Stigter; Christine Willekes; Maria G van Pampus
Journal:  BMC Pregnancy Childbirth       Date:  2007-07-27       Impact factor: 3.007

Review 7.  Placental disease and the maternal syndrome of preeclampsia: missing links?

Authors:  Dionne Tannetta; Ian Sargent
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 8.  Renal and cardiovascular repercussions in preeclampsia and their impact on fluid management: a literature review.

Authors:  Wallace Andrino da Silva; Aline Macedo Pinheiro; Paulo Henrique Lima; Luiz Marcelo S Malbouisson
Journal:  Braz J Anesthesiol       Date:  2021-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.